EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Barriers to medication adherence in sickle cell disease: A comprehensive theory‐based evaluation using the COM‐B model

Kathryn King iD, Stephanie Cai, Leonardo Barrera, Paavani Reddy, Mallorie B Heneghan, Sherif M Badawy iD

Pediatric Blood & Cancer · 2023-09 · 70 (9)

DOI: 10.1002/pbc.30440 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 27.05.2023. Verfasst von Kathryn King und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Oncology and Stem Cell Transplantation, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sickle cell disease (SCD) affects more than 100,000 Americans, with complications such as pain episodes and acute chest syndrome. Despite the efficacy of hydroxyurea in reducing these complications, adherence remains low. Study objectives were to examine barriers to hydroxyurea adherence, and to evaluate the relationship between barriers and their impact on adherence.

Methods

In this cross‐sectional study, patients with SCD and their caregivers were enrolled if they were taking hydroxyurea. Study measures included demographics, self‐report of adherence using visual analog scale (VAS), and the Disease Management and Barriers Interview (DMI)‐SCD. The DMI‐SCD was mapped to the Capability, Opportunity, Motivation, and Behavior (COM‐B) model.

Results

Forty‐eight caregivers (females 83%, median age 38 [34–43]) and 19 patients (male 53%, median age 15 [13.5–18]) participated. Using VAS, many patients (63%) reported low hydroxyurea adherence, while most caregivers (75%) reported high adherence. Caregivers endorsed barriers across multiple COM‐B components, with physical opportunity (e.g., cost) and reflective motivation (e.g., SCD perceptions) being the most identified categories (48% and 42%), respectively. Patients’ most identified barriers included psychological capability (e.g., forgetfulness) and reflective motivation (84% and 68%), respectively. Patients’ and caregivers’ VAS scores negatively correlated with the number of barriers ( r s = –.53, p = .01; r s = –.28, p = .05) and COM‐B categories ( r s = –.51, p = .02; r s = –.35, p = .01), respectively, suggesting lower adherence with more endorsed barriers.

Conclusions

Fewer barriers to hydroxyurea adherence were associated with higher adherence. Understanding barriers to adherence is essential to develop tailored interventions aimed at improving adherence.

Schlagwörter

Stichwörter der Autor:innen

COM-Badherencebarriersbehavior change wheelhydroxyureasickle cell

Autor:innen und Institutionen

  • Division of Hematology, Oncology and Stem Cell Transplantation, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
  • Department of Obstetrics & Gynecology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Mary Ann & J. Milburn Smith Child Health Research, Outreach, and Advocacy Center, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
  • Department of Medical Education, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Utah, Salt Lake City, Utah, USA.
  • Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

ORCID-Profile: Kathryn King, Sherif M Badawy

Förderung

  • NHLBI NIH HHS

Zitieren

APA

King, K., Cai, S., Barrera, L., Reddy, P., Heneghan, M. B., & Badawy, S. M. (2023). Barriers to medication adherence in sickle cell disease: A comprehensive theory‐based evaluation using the COM‐B model. Pediatric Blood & Cancer, 70(9). https://doi.org/10.1002/pbc.30440

Vancouver

King K, Cai S, Barrera L, Reddy P, Heneghan MB, Badawy SM. Barriers to medication adherence in sickle cell disease: A comprehensive theory‐based evaluation using the COM‐B model. Pediatric Blood & Cancer. 2023;70(9). doi:10.1002/pbc.30440

BibTeX
@article{King2023,
  author = {King, Kathryn and Cai, Stephanie and Barrera, Leonardo and Reddy, Paavani and Heneghan, Mallorie B and Badawy, Sherif M},
  title = {Barriers to medication adherence in sickle cell disease: A comprehensive theory‐based evaluation using the COM‐B model},
  journal = {Pediatric Blood & Cancer},
  year = {2023},
  volume = {70},
  number = {9},
  doi = {10.1002/pbc.30440}
}
Kostenlos starten →